Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what NHS England’s procurement policy is for tumour profiling tests to guide adjuvant chemotherapy decisions in early stage breast cancer.
NHS England does not procure tumour profiling tests directly. The National Genomic Test Directory identifies the testing that should be available in the National Health Service and delivered through the Genomic Laboratory infrastructure. Decisions about the specific platforms used to deliver the testing are determined locally.
NHS England does not centrally hold information for the number of people offered and tested with tumour profiling tests to guide adjuvant chemotherapy decisions for early breast cancer in each clinical commissioning group area in England.